Mirikizumab-mrkz Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Mirikizumab-mrkz Injection (injection) from Eli Lilly And Co. with status To Be Discontinued. The shortage was first posted on Dec 22, 2025.
Shortage details
- Status
- To Be Discontinued
- Company
- Eli Lilly And Co.
- Package NDC
- 0002-8870-27
- Dosage Form
- Injection
- Presentation
- Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)
- Initial Posting
- Dec 22, 2025